
SBC Medical (SBC) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
43.4M
Gross Profit
30.0M
69.21%
Operating Income
14.6M
33.57%
Net Income
2.4M
5.63%
EPS (Diluted)
$0.02
Balance Sheet Metrics
Total Assets
284.6M
Total Liabilities
58.3M
Shareholders Equity
226.3M
Debt to Equity
0.26
Cash Flow Metrics
Operating Cash Flow
22.9M
Free Cash Flow
1.2M
Revenue & Profitability Trend
SBC Medical Income Statement From 2022 to 2024
Metric | 2024 | 2023 | 2022 |
---|---|---|---|
Revenue | 205.4M | 193.5M | 174.2M |
Cost of Goods Sold | 49.4M | 56.2M | 59.3M |
Gross Profit | 156.1M | 137.3M | 114.8M |
Gross Margin % | 76.0% | 70.9% | 65.9% |
Operating Expenses | |||
Research & Development | - | - | - |
Selling, General & Administrative | 70.7M | 66.2M | 93.5M |
Other Operating Expenses | - | - | - |
Total Operating Expenses | 70.7M | 66.2M | 93.5M |
Operating Income | 85.4M | 71.1M | 21.3M |
Operating Margin % | 41.6% | 36.7% | 12.3% |
Non-Operating Items | |||
Interest Income | 19.9K | 86.7K | 472.4K |
Interest Expense | 28.3K | 45.3K | 31.4K |
Other Non-Operating Income | -11.9M | 2.5M | 1.9M |
Pre-tax Income | 73.5M | 73.6M | 23.7M |
Income Tax | 26.8M | 35.0M | 18.1M |
Effective Tax Rate % | 36.4% | 47.6% | 76.5% |
Net Income | 46.7M | 38.6M | 5.6M |
Net Margin % | 22.7% | 19.9% | 3.2% |
Key Metrics | |||
EBITDA | 88.5M | 86.3M | 30.9M |
EPS (Basic) | $0.48 | $0.39 | $0.06 |
EPS (Diluted) | $0.48 | $0.39 | $0.06 |
Basic Shares Outstanding | 96561041 | 100743253 | 100743253 |
Diluted Shares Outstanding | 96561041 | 100743253 | 100743253 |
Income Statement Trend
SBC Medical Balance Sheet From 2022 to 2024
Metric | 2024 | 2023 | 2022 |
---|---|---|---|
Assets | |||
Current Assets | |||
Cash & Equivalents | 125.0M | 103.0M | 51.7M |
Short-term Investments | - | 0 | 1.9M |
Accounts Receivable | 30.3M | 35.1M | 13.1M |
Inventory | 1.5M | 3.1M | 1.4M |
Other Current Assets | 25.5K | 162.1K | 37.2K |
Total Current Assets | 184.5M | 165.9M | 112.9M |
Non-Current Assets | |||
Property, Plant & Equipment | 5.3M | 5.9M | 5.5M |
Goodwill | 10.8M | 26.9M | 15.0M |
Intangible Assets | 1.6M | 19.7M | 7.3M |
Long-term Investments | - | - | - |
Other Non-Current Assets | 30.2M | 15.2M | 25.4M |
Total Non-Current Assets | 81.6M | 92.9M | 112.5M |
Total Assets | 266.1M | 258.8M | 225.5M |
Liabilities | |||
Current Liabilities | |||
Accounts Payable | 14.5M | 26.5M | 15.3M |
Short-term Debt | 4.5M | 7.4M | 8.2M |
Current Portion of Long-term Debt | - | - | - |
Other Current Liabilities | 227.9K | 832.5K | 2.3M |
Total Current Liabilities | 61.2M | 92.5M | 101.3M |
Non-Current Liabilities | |||
Long-term Debt | 7.7M | 15.5M | 7.9M |
Deferred Tax Liabilities | 926.0K | 6.0M | 7.3M |
Other Non-Current Liabilities | 1.2M | 1.1M | 1.2M |
Total Non-Current Liabilities | 9.9M | 22.5M | 16.4M |
Total Liabilities | 71.1M | 115.0M | 117.6M |
Equity | |||
Common Stock | 10.3K | 9.4K | 0 |
Retained Earnings | 189.5M | 142.8M | 103.5M |
Treasury Stock | 2.7M | 0 | - |
Other Equity | - | - | - |
Total Shareholders Equity | 195.0M | 143.8M | 107.9M |
Key Metrics | |||
Total Debt | 12.2M | 22.9M | 16.1M |
Working Capital | 123.3M | 73.5M | 11.7M |
Balance Sheet Composition
SBC Medical Cash Flow Statement From 2022 to 2024
Metric | 2024 | 2023 | 2022 |
---|---|---|---|
Operating Activities | |||
Net Income | 46.7M | 38.6M | 5.6M |
Depreciation & Amortization | 3.8M | 12.2M | 5.9M |
Stock-Based Compensation | 13.0M | 0 | - |
Working Capital Changes | -10.9M | -3.9M | -21.8M |
Operating Cash Flow | 42.1M | 54.3M | -10.8M |
Investing Activities | |||
Capital Expenditures | -3.4M | -1.5M | -22.7M |
Acquisitions | -5.1M | 722.6K | -6.5M |
Investment Purchases | -331.5K | -2.1M | -2.6M |
Investment Sales | 0 | 4.1M | 0 |
Investing Cash Flow | -10.1M | 3.5M | -32.7M |
Financing Activities | |||
Share Repurchases | - | - | - |
Dividends Paid | - | - | - |
Debt Issuance | 12.1M | 12.3M | 124.2K |
Debt Repayment | -119.0K | -8.7M | -5.2M |
Financing Cash Flow | 22.9M | 6.1M | -8.0M |
Free Cash Flow | 17.2M | 39.5M | -25.0M |
Net Change in Cash | 54.9M | 63.9M | -51.4M |
Cash Flow Trend
SBC Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
12.78
Forward P/E
0.39
Price to Book
1.72
Price to Sales
2.23
PEG Ratio
-0.14
Profitability Ratios
Profit Margin
17.71%
Operating Margin
33.57%
Return on Equity
16.44%
Return on Assets
15.86%
Financial Health
Current Ratio
3.98
Debt to Equity
6.35
Beta
1.27
Per Share Data
EPS (TTM)
$0.32
Book Value per Share
$2.37
Revenue per Share
$1.86
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
sbc | 420.1M | 12.78 | 1.72 | 16.44% | 17.71% | 6.35 |
Verisk Analytics | 37.9B | 42.02 | 121.47 | 243.11% | 30.68% | 1,096.55 |
Equifax | 30.5B | 48.25 | 6.00 | 12.76% | 10.95% | 93.55 |
Icf International | 1.8B | 17.11 | 1.81 | 11.09% | 5.45% | 64.70 |
Diginex | 1.4B | -175.42 | 197.13 | -114.37% | -255.46% | 5.22 |
CRA International | 1.3B | 23.14 | 6.37 | 29.09% | 7.93% | 113.65 |
Financial data is updated regularly. All figures are in the company's reporting currency.